CDKN2A and ovarian carcinoma: Jiang et al.18 reported that SMYD3 binds to and represses the transcription of tumor suppressor CDKN2A through H4K20me3, while it also binds to and activates the transcription of BIRC3 through H3K4me3 in ovarian cancer cell lines.